Tue, February 10, 2009
Mon, February 9, 2009
Sun, February 8, 2009
Fri, February 6, 2009
Thu, February 5, 2009
Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009

Ligand to Present at BIO CEO and Investor Conference on February 9


//health-fitness.news-articles.net/content/2009/ .. o-ceo-and-investor-conference-on-february-9.html
Published in Health and Fitness on Tuesday, February 3rd 2009 at 13:57 GMT, Last Modified on 2009-02-03 13:57:49 by Market Wire   Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that President and Chief Executive Officer, John L. Higgins and Vice President of Discovery Research, Dr. Martin Meglasson will both present at the BIO CEO and Investor Conference on Monday, February 9, 2009, at 9:00 a.m. Eastern time (6:00 a.m. Pacific). The conference takes place at the Waldorf-Astoria Hotel in New York City.

A live webcast of the presentation will be available on the Company's website [ www.ligand.com ]. A replay of the presentation will be archived on the site for 30 days.

About Ligand Pharmaceuticals

Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases and anemia. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology.


Publication Contributing Sources